Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Clinical trial NCT01795911 · COMPLETED
Trial details
- NCT number
- NCT01795911
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.